Aanjaneya Lifecare is currently trading at Rs 471.00, up by 4.15 points or 0.89% from its previous closing of Rs 466.85 on the BSE.
The scrip opened at Rs 472.00 and has touched a high and low of Rs 487.80 and Rs 467.80 respectively. So far 3,11,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 487.80 on 16-Aug-2011 and a 52 week low of Rs 224.00 on 22-May-2011.
Last one week high and low of the scrip stood at Rs 487.80 and Rs 373.00 respectively. The current market cap of the company is Rs 592 crore.
The promoters holding in the company stood at 60.24% while Institutions and Non-Institutions held 4.81% and 34.95% respectively.
Aanjaneya Lifecare has reported results for the quarter ended June 30, 2011.
The company’s net profit rose by 57.62% year-on-year to Rs 11.27 crore for the quarter ended June 30, 2011 against Rs 7.15 crore for the same quarter last fiscal. Net sales of the company for the quarter ended June 30, 2011, stood at Rs 100.24 crore up by 33.12%, as against Rs 75.30 crore for the corresponding period last fiscal.
Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: